YU32003A - Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje - Google Patents
Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanjeInfo
- Publication number
- YU32003A YU32003A YU32003A YUP32003A YU32003A YU 32003 A YU32003 A YU 32003A YU 32003 A YU32003 A YU 32003A YU P32003 A YUP32003 A YU P32003A YU 32003 A YU32003 A YU 32003A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- processes
- ondansteron
- hydrochloride
- preparation
- novel crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Predmet pronalaska obezbedjune nove kristalne, polimorfne i solvate oblike ondansteron hlorovodonika. Takodje su obezbedjeni postupci za primanje i medjusobno pretvaranje polimorfnih oblika. Dalje su obezbedjeni farmaceutski preparati i terapeutski postupci za upotrebu novih polimorfnih oblika i hidrata.[The present invention provides novel ondansetron hydrochloride crystalline polymorphic forms and solvates. Processes for making and interconverting the polymorphic forms are also provided. Further provided are pharmaceutical compositions and therapeutic methods using the novel polymorphic forms and hydrates.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24428300P | 2000-10-30 | 2000-10-30 | |
US25381900P | 2000-11-29 | 2000-11-29 | |
US26553901P | 2001-01-31 | 2001-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU32003A true YU32003A (sh) | 2006-05-25 |
Family
ID=27399743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU32003A YU32003A (sh) | 2000-10-30 | 2001-10-30 | Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje |
Country Status (20)
Country | Link |
---|---|
US (1) | US20020107275A1 (sh) |
EP (1) | EP1339707A2 (sh) |
JP (1) | JP2004525083A (sh) |
KR (1) | KR20030042038A (sh) |
CN (1) | CN1498216A (sh) |
AU (1) | AU2002230935A1 (sh) |
CA (1) | CA2426026A1 (sh) |
CZ (1) | CZ20031397A3 (sh) |
DE (1) | DE01991193T1 (sh) |
ES (1) | ES2204358T1 (sh) |
HR (1) | HRP20030432A2 (sh) |
HU (1) | HUP0401239A2 (sh) |
IL (1) | IL155644A0 (sh) |
IS (1) | IS6797A (sh) |
MX (1) | MXPA03003761A (sh) |
NO (1) | NO20031928L (sh) |
PL (1) | PL366150A1 (sh) |
SK (1) | SK6182003A3 (sh) |
WO (1) | WO2002036558A2 (sh) |
YU (1) | YU32003A (sh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1355881A4 (en) * | 2001-01-11 | 2004-03-31 | Teva Pharma | IMPROVED METHOD FOR PRODUCING PURE ONDANSETRONHYDROCHLORIDE DIHYDRATE |
JP2005529142A (ja) | 2002-04-29 | 2005-09-29 | テバ ジョジセルジャール レースベニュタールシャシャーグ | 1,2,3,9−テトラヒドロ−9−メチル−3−[(2−メチル−1h−イミダゾル−1−イル)メチル]−4h−カルバゾル−4−オンの製造方法 |
FI6164U1 (fi) * | 2003-01-09 | 2004-03-15 | Synthon Bv | Ondansetronmuotoja |
WO2006046253A1 (en) * | 2004-10-26 | 2006-05-04 | Ipca Laboratories Limited | A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o |
BRPI0707324A2 (pt) * | 2006-01-27 | 2011-05-03 | Eurand Inc | sistemas de fornecimento de fármaco compreendendo agente de bloqueio de serotonina 5-ht3 seletivo fracamente básico e ácidos orgánicos |
AU2007211101B2 (en) * | 2006-01-27 | 2013-05-02 | Adare Pharmaceuticals, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
WO2008073757A1 (en) * | 2006-12-07 | 2008-06-19 | Helsinn Healthcare Sa | Crystalline and amorphous forms of palonosetron hydrochloride |
US8133506B2 (en) | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
CN102190595A (zh) * | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀溴化氢水合物及其制备方法 |
CN102190594A (zh) * | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀氯化氢水合物及其制备方法 |
RU2021125455A (ru) | 2013-11-15 | 2021-10-05 | Экебиа Терапьютикс, Инк. | Твердые формы { [5-(3-хлорфенил)-3-гидроксипиридин-2-карбонил]амино} уксусной кислоты, их композиции и применения |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
EP0201165B1 (en) * | 1985-03-14 | 1994-07-20 | Beecham Group Plc | Medicaments for the treatment of emesis |
GB8518742D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Process |
GB8518741D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Process |
GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
US5344658A (en) * | 1989-06-28 | 1994-09-06 | Glaxo Group Limited | Process and composition using ondansetron |
WO1993000074A1 (en) * | 1991-06-26 | 1993-01-07 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
CA2106642C (en) * | 1992-10-14 | 2005-08-16 | Peter Bod | Carbazolone derivatives and process for preparing the same |
GB9423588D0 (en) * | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
GB9423511D0 (en) * | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
CN1045437C (zh) * | 1994-12-29 | 1999-10-06 | 中国科学院上海有机化学研究所 | 恩丹西酮及其生理盐的合成 |
EP1207160A1 (en) * | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
JP2005529142A (ja) * | 2002-04-29 | 2005-09-29 | テバ ジョジセルジャール レースベニュタールシャシャーグ | 1,2,3,9−テトラヒドロ−9−メチル−3−[(2−メチル−1h−イミダゾル−1−イル)メチル]−4h−カルバゾル−4−オンの製造方法 |
AU2003223763A1 (en) * | 2002-04-30 | 2003-11-17 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
-
2001
- 2001-10-30 MX MXPA03003761A patent/MXPA03003761A/es unknown
- 2001-10-30 KR KR10-2003-7005876A patent/KR20030042038A/ko not_active Application Discontinuation
- 2001-10-30 IL IL15564401A patent/IL155644A0/xx unknown
- 2001-10-30 CN CNA018183859A patent/CN1498216A/zh active Pending
- 2001-10-30 YU YU32003A patent/YU32003A/sh unknown
- 2001-10-30 WO PCT/US2001/048720 patent/WO2002036558A2/en not_active Application Discontinuation
- 2001-10-30 DE DE0001339707T patent/DE01991193T1/de active Pending
- 2001-10-30 JP JP2002539318A patent/JP2004525083A/ja active Pending
- 2001-10-30 CA CA002426026A patent/CA2426026A1/en not_active Abandoned
- 2001-10-30 AU AU2002230935A patent/AU2002230935A1/en not_active Abandoned
- 2001-10-30 EP EP01991193A patent/EP1339707A2/en not_active Withdrawn
- 2001-10-30 ES ES01991193T patent/ES2204358T1/es active Pending
- 2001-10-30 SK SK618-2003A patent/SK6182003A3/sk not_active Application Discontinuation
- 2001-10-30 PL PL01366150A patent/PL366150A1/xx unknown
- 2001-10-30 CZ CZ20031397A patent/CZ20031397A3/cs unknown
- 2001-10-30 HU HU0401239A patent/HUP0401239A2/hu unknown
- 2001-10-30 US US10/016,752 patent/US20020107275A1/en not_active Abandoned
-
2003
- 2003-04-29 IS IS6797A patent/IS6797A/is unknown
- 2003-04-29 NO NO20031928A patent/NO20031928L/no not_active Application Discontinuation
- 2003-05-28 HR HR20030432A patent/HRP20030432A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0401239A2 (hu) | 2004-12-28 |
IS6797A (is) | 2003-04-29 |
NO20031928D0 (no) | 2003-04-29 |
CA2426026A1 (en) | 2002-05-10 |
KR20030042038A (ko) | 2003-05-27 |
DE01991193T1 (de) | 2004-07-08 |
AU2002230935A1 (en) | 2002-05-15 |
WO2002036558A3 (en) | 2003-02-06 |
WO2002036558A2 (en) | 2002-05-10 |
CZ20031397A3 (cs) | 2003-11-12 |
MXPA03003761A (es) | 2003-07-28 |
US20020107275A1 (en) | 2002-08-08 |
SK6182003A3 (en) | 2004-03-02 |
HRP20030432A2 (en) | 2004-06-30 |
EP1339707A2 (en) | 2003-09-03 |
PL366150A1 (en) | 2005-01-24 |
JP2004525083A (ja) | 2004-08-19 |
ES2204358T1 (es) | 2004-05-01 |
NO20031928L (no) | 2003-06-27 |
CN1498216A (zh) | 2004-05-19 |
IL155644A0 (en) | 2003-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1830A (en) | Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same. | |
TW200613243A (en) | Novel compounds | |
MX2007005221A (es) | Formas cristalinas de ascomicina y preparacion de ellas. | |
MY136430A (en) | N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation | |
HK1087695A1 (en) | Process for the preparation of n-substituted 2-cyanopyrrolidines n- 2- | |
EP1752448A3 (en) | Fluvastatin sodium crystal form lxxix, processes for preparing it, compositions containing it and methods of using it | |
YU32003A (sh) | Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje | |
DE60122216D1 (de) | Zolpidem Hemitartrat Solvat | |
SE0302192D0 (sv) | Novel compounds | |
TNSN04024A1 (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation | |
MXPA04001646A (es) | Composicion oftalmica que comprende ascomicina. | |
MXPA04001968A (es) | Agentes antidiabeticos. | |
WO2005065018A3 (en) | Crystalline forms of (6r) -l-erythro-tetrahydrobiopterin dihydrochloride | |
HUP0200580A2 (hu) | Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
MXPA04005305A (es) | Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo. | |
ES2159260A1 (es) | Nueva composicion de metanosulfonato de paroxetina | |
NO20024503L (no) | FremgangsmÕte for tilveiebringelse av startkulturer med en konsistent kvalitet | |
MXPA04005307A (es) | Clorhidrato de venlafaxina en forma de monohidrato y sus metodos de preparacion. | |
HUP0401161A3 (en) | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride, process for their preparation and pharmaceutical compositions containing the crystalline forms | |
MX2007000093A (es) | Formas cristalinas de 1,24(s)-dihidroxi vitamina d2. | |
EP1406614A4 (en) | CARVEDILOLPOLYMORPH | |
PL359727A1 (en) | Crystalline pharmaceutical | |
AU2002341901A1 (en) | Novel compositions of carvedilol | |
NO20053829D0 (no) | Fremgangsmate og intermediater for fremstilling av olanzapin. | |
WO2003045909A3 (en) | Methods and intermediates for the synthesis of azepines |